| abstract |
This invention provides compounds that have bioaffector and drug properties; its pharmaceutical compositions and method of use. In particular, the invention relates to azaindoloxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, either when used alone or in combination with other antiviral, anti-infective, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS. |